Company intelligence / Profile preview

Cadex Genomics

Redwood City, California, United Statescadexgenomics.com ↗
Ownership
Private
Employees
~3
Development stage
Preclinical
01

Overview

Cadex Genomics has developed Alibrex, a blood-based liquid biopsy assay that uses retrotransposon-targeted qPCR to monitor real-time therapy response in patients with stage IV solid tumors. The technology enables oncologists to assess treatment effectiveness within weeks, potentially allowing earlier adjustments to care compared to standard imaging or mutation-matching ctDNA tests. Clinical results indicate the platform can deliver actionable information within 48 hours after specimen collection, improving timeliness and cost-effectiveness over existing methods. No published large-scale clinical trial data found.

Therapeutic areas
Oncology
Modalities
Diagnostic assay (liquid biopsy)qPCR-based test
Industry
Molecular Diagnostics
02

Drug pipeline

1 asset

Alibrex

Pre-commercial
Indications
Stage IV colorectal cancer, Stage IV breast cancer, Stage IV lung cancer
03

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Cadex Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadex Genomics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call